Regeneron Pharmaceuticals (REGN) Interest Coverage Ratio (2009 - 2026)

Regeneron Pharmaceuticals' Interest Coverage Ratio history runs 18 years deep, the most recent figure standing at 22.72 for Q1 2026.

• On a quarterly basis, Interest Coverage Ratio fell 32.04% year-over-year to 22.72 in Q1 2026; TTM through Mar 2026 was 128.24, a 40.75% decrease from a year earlier, with the FY2025 full-year figure at 28.85, up 359.41% from the prior year.
• Interest Coverage Ratio advanced to 22.72 in Q1 2026 per REGN's latest filing, from 13.73 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 105.83 in Q2 2025 and bottomed at 3.53 in Q3 2022.
• The 5-year median for Interest Coverage Ratio is 13.73 (2025), against an average of 27.05.
• Across the five-year window, Interest Coverage Ratio sank 98.31% in 2022 and surged 814.66% in 2024, its largest moves.
• Year by year, Interest Coverage Ratio stood at 65.91 in 2022, then declined by 19.77% to 52.88 in 2023, then tumbled by 58.84% to 21.76 in 2024, then sank by 36.92% to 13.73 in 2025, then jumped by 65.49% to 22.72 in 2026.
• Per Business Quant, the three latest REGN Interest Coverage Ratio figures stand at 22.72 (Q1 2026), 13.73 (Q4 2025), and 53.2 (Q3 2025).